These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 28309)

  • 1. Rapamycin (AY-22,989), a new antifungal antibiotic. III. In vitro and in vivo evaluation.
    Baker H; Sidorowicz A; Sehgal SN; Vézina C
    J Antibiot (Tokyo); 1978 Jun; 31(6):539-45. PubMed ID: 28309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.
    Sehgal SN; Baker H; Vézina C
    J Antibiot (Tokyo); 1975 Oct; 28(10):727-32. PubMed ID: 1102509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimycotic activity in vitro and in vivo of a new hydrosoluble polyene antibiotic.
    Strippoli V; Evangelista AM; Simonetti N
    Farmaco Sci; 1976 Dec; 31(12):891-900. PubMed ID: 1017483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo anti-Candida activity and toxicology of LY121019.
    Gordee RS; Zeckner DJ; Ellis LF; Thakkar AL; Howard LC
    J Antibiot (Tokyo); 1984 Sep; 37(9):1054-65. PubMed ID: 6389460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of Candida albicans from patients with chronic oral candidiasis.
    Holbrook WP; Kippax R
    Postgrad Med J; 1979 Sep; 55(647):692-4. PubMed ID: 392486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents.
    Ellepola AN; Samaranayake LP
    Arch Oral Biol; 1998 Dec; 43(12):999-1007. PubMed ID: 9877331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the partricin derivative SPA-S-753 against systemic murine candidosis.
    Clemons KV; Stevens DA
    J Antimicrob Chemother; 2001 Feb; 47(2):183-6. PubMed ID: 11157903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of antifungal polyenes on the adhesion of Candida albicans and Candida glabrata to human epithelial cells in vitro.
    Dorocka-Bobkowska B; Konopka K; Düzgüneş N
    Arch Oral Biol; 2003 Dec; 48(12):805-14. PubMed ID: 14596870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibilities of Zygomycota to polyenes.
    Dannaoui E; Meis JF; Mouton JW; Verweij PE;
    J Antimicrob Chemother; 2002 May; 49(5):741-4. PubMed ID: 12003966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of brief exposure to antifungal agents on the post-antifungal effect and hemolysin activity of oral Candida albicans.
    Ellepola AN; Khajah R; Jayatilake S; Samaranayake L; Sharma P; Khan Z
    J Appl Oral Sci; 2015; 23(4):412-8. PubMed ID: 26398514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of brief and sequential exposure to nystatin, amphotericin B, ketoconazole, and fluconazole in modulating adhesion traits of oral Candida dubliniensis isolates.
    Ellepola AN; Joseph BK; Samaranayake LP; Bandara HM; Khan ZU
    J Investig Clin Dent; 2016 May; 7(2):149-57. PubMed ID: 25388637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cispentacin, a new antifungal antibiotic. II. In vitro and in vivo antifungal activities.
    Oki T; Hirano M; Tomatsu K; Numata K; Kamei H
    J Antibiot (Tokyo); 1989 Dec; 42(12):1756-62. PubMed ID: 2621158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of orally administered polyene antimycotics on the intestinal colonization with yeasts: possibilities and limitations].
    Blaschke-Hellmessen R; Buchmann H; Schwarze R
    Mycoses; 1996; 39 Suppl 1():33-9. PubMed ID: 8767267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model.
    Andes D; Stamsted T; Conklin R
    Antimicrob Agents Chemother; 2001 Mar; 45(3):922-6. PubMed ID: 11181381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells.
    Brenciaglia MI; Ghezzi MC; Cipriani P; Mancini C; Trancassini M
    Chemioterapia; 1986 Jun; 5(3):200-3. PubMed ID: 3521918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular phospholipase production of oral Candida albicans isolates from smokers, diabetics, asthmatics, denture wearers and healthy individuals following brief exposure to polyene, echinocandin and azole antimycotics.
    Ellepola AN; Samaranayake LP; Khan ZU
    Braz J Microbiol; 2016; 47(4):911-916. PubMed ID: 27522928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The release of potassium ions from Candida albicans in the presence of polyene antibiotics.
    Gale EF
    J Gen Microbiol; 1974 Feb; 80(2):451-65. PubMed ID: 4596987
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibiotic X-63 in experimental candidiasis of mice.
    Gupta HP; Mathur IS; Gupta SK
    Chemotherapy; 1978; 24(1):39-44. PubMed ID: 618723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.